Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients.

Item

http://www.wikidata.org/entity/Q52026563

description

2000 nî lūn-bûn

@nan

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

2000年學術文章

@zh-hant

name

Increased expression of non-fu ...... D8+ cells of myeloma patients.

@en

Increased expression of non-fu ...... D8+ cells of myeloma patients.

@nl

type

Item

label

Increased expression of non-fu ...... D8+ cells of myeloma patients.

@en

Increased expression of non-fu ...... D8+ cells of myeloma patients.

@nl

prefLabel

Increased expression of non-fu ...... D8+ cells of myeloma patients.

@en

Increased expression of non-fu ...... D8+ cells of myeloma patients.

@nl

P1476

Increased expression of non-fu ...... D8+ cells of myeloma patients.

@en

P2093

Beggiato E

http://www.w3.org/2001/XMLSchema#string

Besostri B

http://www.w3.org/2001/XMLSchema#string

Bianchi A

http://www.w3.org/2001/XMLSchema#string

Boccadoro M

http://www.w3.org/2001/XMLSchema#string

Coscia M

http://www.w3.org/2001/XMLSchema#string

Foglietta M

http://www.w3.org/2001/XMLSchema#string

Mariani S

http://www.w3.org/2001/XMLSchema#string

Massaia M

http://www.w3.org/2001/XMLSchema#string

Moretta L

http://www.w3.org/2001/XMLSchema#string

Peola S

http://www.w3.org/2001/XMLSchema#string

P2860

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

Enhancement of antitumor immunity by CTLA-4 blockade

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

Regulation of KIR expression in human T cells: a safety mechanism that may impair protective T-cell responses.

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.

A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.

HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A

Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: impairment of specific cytolytic functions

Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations.

P304

46-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2141.2000.01981.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

109

http://www.w3.org/2001/XMLSchema#string

P577

2000-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12469308

http://www.w3.org/2001/XMLSchema#string

P698

10848781

http://www.w3.org/2001/XMLSchema#string